| 141 |
|
Brief report Contribution of beta-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS)/
|
Gatto, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 142 |
|
Brief report DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1/
|
Sanui, T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 143 |
|
Brief report Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population/
|
Kustikova, O. S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 144 |
|
Brief report Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AML/
|
Estey, E. H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 145 |
|
Brief report Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome/
|
Cortes, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 146 |
|
Brief report Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages/
|
Fantuzzi, L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 147 |
|
Brief report Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies/
|
Faderl, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 148 |
|
Brief report Factor VII gene intronic mutation in a lethal factor VII deficiency: effects on splice-site selection/
|
Borensztajn, K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 149 |
|
Brief report Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control/
|
Li, X
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 150 |
|
Brief report Functional p85alpha gene is required for normal murine fetal erythropoiesis/
|
Huddleston, H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 151 |
|
Brief report GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome/
|
Hitzler, J. K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 152 |
|
Brief report G-protein-coupled receptor S1P~1 acts within endothelial cells to regulate vascular maturation/
|
Allende, M. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 153 |
|
Brief report Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E~2-induced fos gene transcription/
|
Sawasdikosol, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 154 |
|
Brief report Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets/
|
Mosnier, L. O
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 155 |
|
Brief report Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells/
|
Rasmussen, T
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 156 |
|
Brief report IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells/
|
Cookson, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 157 |
|
Brief report Imatinib mesylate inhibits autonomous erythropoiesis in patients with polycythemia vera in vitro/
|
Oehler, L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 158 |
|
Brief report Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571)/
|
Wohlbold, L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 159 |
|
Brief report Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia/
|
Branger, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 160 |
|
Brief report IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity/
|
Crow, A. R
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|